Heteromeric KCNE2/KCNQ1 potassium channels in the luminal membrane of gastric parietal cells |
| |
Authors: | Dirk Heitzmann,Florian Grahammer,Thomas von Hahn,Annette Schmitt-Grä ff,Elisa Romeo,Roland Nitschke,Uwe Gerlach,Hans Jochen Lang,Franç ois Verrey,Jacques Barhanin, Richard Warth |
| |
Affiliation: | Institute of Physiology, Universitätsstrasse 31, 93053 Regensburg, Germany;Institute of Physiology, Gmelinstrasse 5, 72076 Tübingen, Germany;IPMC, CNRS, 660 Route des Lucioles, 06560 Valbonne Sophia Antipolis, France;Institute of Pathology, Albertstrasse 19, 79104 Freiburg, Germany;Institute of Physiology, Winterthurerstrasse 190, 8057 Zürich, Switzerland;Institute of Biology I, Hauptstrasse 1, 79104 Freiburg, Germany;Aventis Pharma GmbH, 65926 Frankfurt, Germany |
| |
Abstract: | Recently, we and others have shown that luminal K+ recycling via KCNQ1 K+ channels is required for gastric H+ secretion. Inhibition of KCNQ1 by the chromanol 293B strongly diminished H+ secretion. The present study aims at clarifying KCNQ1 subunit composition, subcellular localization, regulation and pharmacology in parietal cells. Using in situ hybridization and immunofluorescence techniques, we identified KCNE2 as the β subunit of KCNQ1 in the luminal membrane compartment of parietal cells. Expressed in COS cells, hKCNE2/hKCNQ1 channels were activated by acidic pH, PIP2, cAMP and purinergic receptor stimulation. Qualitatively similar results were obtained in mouse parietal cells. Confocal microscopy revealed stimulation-induced translocation of H+,K+-ATPase from tubulovesicles towards the luminal pole of parietal cells, whereas distribution of KCNQ1 K+ channels did not change to the same extent. In COS cells the 293B-related substance IKs124 blocked hKCNE2/hKCNQ1 with an IC50 of 8 n m . Inhibition of hKCNE1- and hKCNE3-containing channels was weaker with IC50 values of 370 and 440 n m , respectively. In conclusion, KCNQ1 coassembles with KCNE2 to form acid-activated luminal K+ channels of parietal cells. KCNQ1/KCNE2 is activated during acid secretion via several pathways but probably not by targeting of the channel to the membrane. IKs124 could serve as a leading compound in the development of subunit-specific KCNE2/KCNQ1 blockers to treat peptic ulcers. |
| |
Keywords: | |
|
|